Atlas Trials

Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis

Clinical trial NCT02275741 · COMPLETED

Trial details

NCT number
NCT02275741
Sponsor
Dr. med. Micha Loebermann
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2009-10-01
Primary completion
2015-09-01
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.